SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-004051
Filing Date
2022-01-07
Accepted
2022-01-07 08:36:04
Documents
14
Period of Report
2022-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d231535d8k.htm   iXBRL 8-K 35338
2 EX-10.1 d231535dex101.htm EX-10.1 709359
3 EX-99.1 d231535dex991.htm EX-99.1 15132
  Complete submission text file 0001193125-22-004051.txt   1060343

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA chrs-20220105.xsd EX-101.SCH 2888
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE chrs-20220105_lab.xml EX-101.LAB 18138
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chrs-20220105_pre.xml EX-101.PRE 11405
8 EXTRACTED XBRL INSTANCE DOCUMENT d231535d8k_htm.xml XML 3368
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 22516561
SIC: 2836 Biological Products, (No Diagnostic Substances)